…the list of potential bidders for ACHN includes the following: Roche BMY ABBV JNJ NVS and many others… You can take JNJ and NVS off your list. JNJ now has a nuke by way of Alios and NVS has exited the HCV arena altogether. By the way, you didn’t comment on the large selling of ACHN by former 10% shareholder, RA Capital (#msg-106809309).